A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Outset Medical, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 46,200 shares of OM stock, worth $39,732. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,200
Previous 65,100 29.03%
Holding current value
$39,732
Previous $250,000 87.6%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.45 - $4.82 $130,765 - $1.4 Million
-290,589 Reduced 99.0%
2,922 $1,000
Q2 2024

Aug 14, 2024

BUY
$1.94 - $4.61 $22,364 - $53,144
11,528 Added 4.09%
293,511 $1.13 Million
Q1 2024

May 15, 2024

SELL
$1.99 - $5.64 $310,141 - $878,994
-155,850 Reduced 35.6%
281,983 $626,000
Q4 2023

Feb 14, 2024

BUY
$3.07 - $10.25 $1.29 Million - $4.3 Million
419,224 Added 2252.8%
437,833 $2.37 Million
Q3 2023

Nov 14, 2023

SELL
$10.52 - $20.68 $142,777 - $280,668
-13,572 Reduced 42.17%
18,609 $202,000
Q2 2023

Aug 14, 2023

SELL
$17.18 - $23.76 $5.88 Million - $8.13 Million
-342,070 Reduced 91.4%
32,181 $703,000
Q1 2023

May 15, 2023

BUY
$18.25 - $30.26 $3.28 Million - $5.43 Million
179,512 Added 92.18%
374,251 $6.89 Million
Q4 2022

Feb 14, 2023

SELL
$12.36 - $26.41 $4.11 Million - $8.79 Million
-332,830 Reduced 63.09%
194,739 $5.03 Million
Q3 2022

Nov 14, 2022

SELL
$14.67 - $21.7 $4.08 Million - $6.04 Million
-278,431 Reduced 34.54%
527,569 $8.4 Million
Q2 2022

Aug 15, 2022

SELL
$13.46 - $48.16 $313,456 - $1.12 Million
-23,288 Reduced 2.81%
806,000 $12 Million
Q1 2022

May 16, 2022

BUY
$34.22 - $47.24 $959,083 - $1.32 Million
28,027 Added 3.5%
829,288 $37.7 Million
Q4 2021

Feb 14, 2022

SELL
$43.29 - $58.77 $9.43 Million - $12.8 Million
-217,773 Reduced 21.37%
801,261 $36.9 Million
Q3 2021

Nov 15, 2021

BUY
$36.86 - $54.98 $13.1 Million - $19.6 Million
356,481 Added 53.8%
1,019,034 $50.4 Million
Q2 2021

Aug 16, 2021

BUY
$41.49 - $59.92 $17.1 Million - $24.7 Million
412,902 Added 165.39%
662,553 $33.1 Million
Q1 2021

May 17, 2021

BUY
$46.94 - $58.66 $6.69 Million - $8.36 Million
142,463 Added 132.91%
249,651 $13.6 Million
Q4 2020

Feb 16, 2021

BUY
$42.51 - $64.0 $3.18 Million - $4.78 Million
74,761 Added 230.55%
107,188 $6.09 Million
Q3 2020

Nov 16, 2020

BUY
$49.75 - $60.68 $1.61 Million - $1.97 Million
32,427 New
32,427 $1.62 Million

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $41.3M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.